Round table "Development of integration - the basis for increasing the level of availability of pharmaceutical products of the EAEU states"

The Eurasian Economic Commission (EEC) hosted a Round table "Development of integration – the basis for increasing the level of availability of pharmaceutical products of the EAEU member States", the main topics of which were the development of import substitution and ensuring drug safety in the Eurasian Economic Union. The president of ACTICOMP, Alexander Semyonov, spoke about the importance of creating the Russian Pharmacopoeia and the Pharmacopoeia of the EAEU and the introduction of his own institute of reference materials: "The existence of his own Pharmacopoeia became especially important when certain problems with the supply of reference samples from the EU and the USA appeared. To stabilize the situation, we need our own institute, and today this is a question of drug safety. Since 2018, our company has been cooperating with the GILS and NP of the Ministry of Industry and Trade of Russia, and today also with the National Center for Standard Samples. We are ready to undertake the development of a total of 270 samples and impurities for active substances with the availability of appropriate equipment and funding. In the next 9 months, it is necessary to launch the development and standardization of samples in Russia and the EAEU. Our common goal is to meet the needs for all drugs from the list of VED."

Round table "Development of integration - the basis for increasing the level of availability of pharmaceutical products of the EAEU states"